Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yang Xue An Shen Tablet is a traditional Chinese medicine (TCM) product developed by Jinsheng Da Ren Tang (Tianjin Pharmaceutical Da Ren Tang Group). It is formulated to nourish yin and blood, and calm the mind (calm the Shen). The tablet is composed of seven key herbal ingredients: Agrimonia pilosa (Xian He Cao), Eclipta prostrata (Mo Han Lian), Spatholobus suberectus (Ji Xue Teng), Rehmannia glutinosa (Sheng Di Huang), Rehmannia glutinosa praeparata (Shu Di Huang), Albizia julibrissin (He Huan Pi), and Polygonum multiflorum (Ye Jiao Teng). It is primarily indicated for the treatment of insomnia, restlessness, anxiety, dizziness, palpitations, and forgetfulness caused by blood deficiency and kidney yin deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yang Xue An Shen Tablet.